Company intelligence / Profile preview

Beyondbmi

Dublin, Ireland

Ownership: Private
Development stage: Commercial

Overview

Beyondbmi has launched a proprietary digital platform that delivers a medically supervised weight loss program. The program combines GLP-1 medication prescriptions with expert-led nutritional therapy and behavioral support. Early results are based on established clinical evidence for GLP-1 therapies; the company aims to demonstrate real-world outcomes similar to those seen in STEP trials (~15% average weight loss over one year). No independent clinical trial data from Beyondbmi have been published yet

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Small molecule (GLP-1 receptor agonists)Non-pharmacological therapy (behavioral and nutritional interventions)Device (digital health platform)
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

ozempic

Commercial

Indications: Obesity, Type 2 diabetes

Partnerships

None disclosed; supported by University College Dublin/NovaUCD academic partnership

Beyond the preview

Go deeper on Beyondbmi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyondbmi.

Explore the full profile